Predictor factor of survival in advanced hepatocellular carcinoma treated with sorafenib ∼a multicenter study∼

被引：0
|
作者：
Ogawa, Chikara [1 ,6 ]
Morita, Masahiro [1 ]
Omura, Akina [1 ]
Shibatoge, Mitsushige [1 ]
Tsutsui, Akemi [2 ]
Senoh, Tomonori [2 ]
Nagano, Takuya [2 ]
Takaguchi, Kouichi [2 ]
Tani, Joji [3 ]
Morishita, Asahiro [3 ]
Yoneyama, Hirohito [3 ]
Masaki, Tsutomu [3 ]
Moriya, Akio [4 ]
Ando, Masaharu [4 ]
Deguchi, Akihiro [5 ]
Kudo, Masatoshi [6 ]
机构：
[1] Takamatsu Red Cross Hosp, Dept Gastroenterol & Hepatol, Takamatsu, Kagawa, Japan
[2] Kagawa Prefectural Cent Hosp, Dept Hepatol, Takamatsu, Kagawa, Japan
[3] Kagawa Univ, Fac Med, Dept Gastroenterol & Neurol, Takamatsu, Kagawa, Japan
[4] Mitoyo Gen Hosp, Dept Gastroenterol, Kanonji, Japan
[5] Kagawa Rosai Hosp, Dept Gastroenterol, Marugame, Japan
[6] Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, Higashiosaka, Osaka, Japan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O1-6-4
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Japan
    Sadahisa Ogasawara
    Yoshihiko Ooka
    Norio Itokawa
    Masanori Inoue
    Shinichiro Okabe
    Atsuyoshi Seki
    Yuki Haga
    Masamichi Obu
    Masanori Atsukawa
    Ei Itobayashi
    Hideaki Mizumoto
    Nobuyuki Sugiura
    Ryosaku Azemoto
    Kengo Kanayama
    Hiroaki Kanzaki
    Susumu Maruta
    Takahiro Maeda
    Yuko Kusakabe
    Masayuki Yokoyama
    Kazufumi Kobayashi
    Soichiro Kiyono
    Masato Nakamura
    Tomoko Saito
    Eiichiro Suzuki
    Shingo Nakamoto
    Shin Yasui
    Akinobu Tawada
    Tetsuhiro Chiba
    Makoto Arai
    Tatsuo Kanda
    Hitoshi Maruyama
    Naoya Kato
    Investigational New Drugs, 2020, 38 : 172 - 180
  • [32] Predictive factors for long-term survival in patients with advanced hepatocellular carcinoma treated with sorafenib
    Reis, Daniela
    Moura, Miguel
    Freitas, Luis Carlos
    Carvalhana, Sofia
    Nogueira, Paulo Jorge
    Gaio, Raquel
    Marinho, Rui Tato
    Cortez-Pinto, Helena
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E114 - E120
  • [33] The Impact of Combined Transarterial Chemoembolization on the Overall Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib
    Chen, Lufeng
    Su, Hongying
    Shao, Haibo
    Xu, Ke
    Liang, Songnian
    Liu, Ling
    HEPATO-GASTROENTEROLOGY, 2014, 61 (131) : 802 - 808
  • [34] Predictive factors for long-term survival in patients with advanced hepatocellular carcinoma treated with sorafenib
    Reis, Daniela
    Moura, Miguel
    Freitas, Luis Carlos
    Carvalhana, Sofia
    Nogueira, Paulo Jorge
    Gaio, Raquel
    Marinho, Rui Tato
    Cortez-Pinto, Helena
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E114 - E120
  • [35] Duration of Stable Disease Is Associated with Overall Survival in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib
    Arizumi, Tadaaki
    Ueshirna, Kazuomi
    Chishina, Hirokazu
    Kono, Masashi
    Takita, Mashiro
    Kitai, Satoshi
    Inoue, Tatsuo
    Yada, Norihisa
    Hagiwara, Satoru
    Minami, Yasunori
    Sakurai, Toshiharu
    Nishida, Naoshi
    Kudo, Masatoshi
    DIGESTIVE DISEASES, 2014, 32 (06) : 705 - 710
  • [36] Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: An Analysis of SEER-Medicare Database
    Parikh, Neehar D.
    Marshall, Vincent D.
    Nathan, Hari
    Balkrishnan, Rajesh
    Shahinian, Vahakn
    HEPATOLOGY, 2015, 62 : 409A - 410A
  • [37] Diarrhea Is a Positive Outcome Predictor for Sorafenib Treatment of Advanced Hepatocellular Carcinoma
    Koschny, Ronald
    Gotthardt, Daniel
    Koehler, Christiane
    Jaeger, Dirk
    Stremmel, Wolfgang
    Ganten, Tom M.
    ONCOLOGY, 2013, 84 (01) : 6 - 13
  • [38] Overall survival predictors in hepatocellular carcinoma patients treated with sorafenib
    da Costa Ferreira, Caroline Petersen
    Ribeiro, Mauricio Alves
    Szutan, Luiz Arnaldo
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 (03): : 275 - 283
  • [39] Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib
    Pinter, M.
    Sieghart, W.
    Hucke, F.
    Graziadei, I.
    Vogel, W.
    Maieron, A.
    Koenigsberg, R.
    Weissmann, A.
    Kornek, G.
    Matejka, J.
    Stauber, R.
    Buder, R.
    Gruenberger, B.
    Schoeniger-Hekele, M.
    Mueller, C.
    Peck-Radosavljevic, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (08) : 949 - 959
  • [40] Post-progression survival and progression-free survival in patients with advanced hepatocellular carcinoma treated by sorafenib
    Terashima, Takeshi
    Yamashita, Tatsuya
    Takata, Noboru
    Nakagawa, Hidetoshi
    Toyama, Tadashi
    Arai, Kuniaki
    Kitamura, Kazuya
    Yamashita, Taro
    Sakai, Yoshio
    Mizukoshi, Eishiro
    Honda, Masao
    Kaneko, Shuichi
    HEPATOLOGY RESEARCH, 2016, 46 (07) : 650 - 656
12345